Medtronic, St. Jude Launch New Quadripolar Devices
This article was originally published in The Gray Sheet
Medtronic has launched two more Attain Performa left ventricular quadripolar leads for the Viva Quad XT and Viva Quad S cardiac resynchronization therapy defibrillators following FDA approval announced Dec. 11. On the same day, St. Jude announced CE mark of the Quadra Allure MP cardiac resynchronization therapy pacemaker, the first quadripolar CRT-P with MultiPoint pacing.
You may also be interested in...
Data highlighted earlier this month at the Heart Rhythm Society annual conference in Boston include results for new ablation systems, quadripolar leads and antibacterial cardiac implant wraps.
Medtronic is set for the U.S. launch of the Viva Quad XT and Viva Quad S cardiac resynchronization devices. Syncardia earns FDA approval for a new propriety valve set for its total artificial heart. Lombard earns Japanese approval for its AAA graft. Philips announces a unique case in Canada.
The firm reported during its second-quarter earnings call that its cardiac rhythm management business has stabilized after several quarters of market share decline.